PHASE-II EVALUATION OF METOPRINE IN ADVANCED PANCREATIC ADENOCARCINOMA

被引：0
|
作者：
STERNBERG, CN [1 ]
MAGILL, GB [1 ]
SORDILLO, PP [1 ]
CHENG, EW [1 ]
KEMENY, N [1 ]
机构：
[1] MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,1275 YORK AVE,NEW YORK,NY 10021
来源：
CANCER TREATMENT REPORTS | 1984年 / 68卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1053 / 1054
页数：2
相关论文
共 50 条
  • [21] MITOXANTRONE THERAPY OF ADVANCED ADENOCARCINOMA OF THE ENDOMETRIUM - A PHASE-II TRIAL
    RUNGE, HM
    MEERPOHL, HG
    PFLEIDERER, A
    ONKOLOGIE, 1989, 12 (02): : 102 - 103
  • [22] PHASE-II STUDY OF BISANTRENE ADMINISTERED BY CONTINUOUS 72-HOUR INFUSION FOR ADVANCED PANCREATIC ADENOCARCINOMA
    MARSCHKE, RF
    KVOLS, LK
    CULLINAN, SA
    LAURIE, JA
    MAILLIARD, JA
    TSCHETTER, LK
    OCONNELL, MJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (04): : 269 - 270
  • [23] PHASE-II CHEMOTHERAPY OF PANCREATIC ADENOCARCINOMA WITH METOPRINE (DDMP) 2,4-DIAMINO-5-(3'4'DICHLOROPHENYL)-6-METHYL-PYRIMIDINE
    STERNBERG, CN
    MAGILL, GB
    CHENG, E
    SORDILLO, PP
    KEMENY, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 149 - 149
  • [24] AN EORTC GASTROINTESTINAL GROUP PHASE-II EVALUATION OF EPIRUBICIN COMBINED WITH IFOSFAMIDE IN ADVANCED ADENOCARCINOMA OF THE PANCREAS
    WILS, J
    BLEIBERG, H
    BUYSE, M
    WAGENER, DT
    SPLINTER, T
    VEENHOF, C
    HERBEN, M
    DUEZ, N
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (07): : 1119 - 1120
  • [25] PHASE-II EVALUATION OF LONIDAMINE IN PATIENTS WITH ADVANCED MALIGNANCY
    EVANS, WK
    SHEPHERD, FA
    MULLIS, B
    ONCOLOGY, 1984, 41 : 69 - 77
  • [26] PHASE-II EVALUATION OF MENOGARIL IN PATIENTS WITH ADVANCED HYPERNEPHROMA
    LONG, HJ
    HAUGE, MD
    THERNEAU, TM
    BUCKNER, JC
    FRYTAK, S
    HAHN, RG
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (03) : 261 - 262
  • [27] PHASE-II EVALUATION OF CARBOPLATIN IN ADVANCED ENDOMETRIAL CARCINOMA
    LONG, HJ
    PFEIFLE, DM
    WIEAND, HS
    KROOK, JE
    EDMONSON, JH
    BUCKNER, JC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (04) : 276 - 278
  • [28] PHASE-II EVALUATION OF ESORUBICIN (4'-DEOXYDOXORUBICIN) IN PANCREATIC ADENOCARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    VAUGHN, CB
    SALMON, SE
    FLEMING, TR
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (01) : 81 - 85
  • [29] EVALUATION OF COMBINATION CHEMOTHERAPY AND PHASE-II AGENTS IN PANCREATIC ADENOCARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BUKOWSKI, RM
    FLEMING, TR
    MACDONALD, JS
    OISHI, N
    TAYLOR, SA
    BAKER, LH
    CANCER, 1993, 71 (02) : 322 - 325
  • [30] PHASE-II STUDY OF 3-DEAZAURIDINE IN ADVANCED COLORECTAL ADENOCARCINOMA
    BRUNO, S
    CREAVEN, PJ
    LEDESMA, E
    POSTER, D
    YOON, J
    MITTELMAN, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (01): : 69 - 71
12345